← back to search

William Charles Kreisl

Columbia University · US
Area of research
Physiology · Psychiatry and Mental health
Research interest
Research focused on Neuroinflammation and Translocator protein, with related work in Neuroscience, Positron emission tomography, Disease. Notable publications include 'Neuroinflammation in psychiatric disorders: PET imaging and promising new targets', 'PET imaging of neuroinflammation in neurological disorders', and 'Antiviral therapy: Valacyclovir Treatment of Alzheimer’s Disease (VALAD) Trial: protocol for a randomised, double-blind,placebo-controlled, treatment trial'.
h-index
citations
824
works
10
NIH funding
primary concept
email

Recent publications

Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-β status, APOE genotype and sex
Nature Neuroscience 2025cited by 30position: middledoi
Valacyclovir Treatment of Early Symptomatic Alzheimer Disease
JAMA 2025cited by 6position: middledoi
Microglia measured by TSPO PET are associated with Alzheimer's disease pathology and mediate key steps in a disease progression model
Alzheimer s & Dementia 2024cited by 36position: middledoi
Olfactory Impairment Is Related to Tau Pathology and Neuroinflammation in Alzheimer’s Disease
Journal of Alzheimer s Disease 2021cited by 52position: lastdoi
Cognitive impairment and World Trade Centre-related exposures
Nature Reviews Neurology 2021cited by 52position: middledoi
Glia Imaging Differentiates Multiple System Atrophy from Parkinson's Disease: A Positron Emission Tomography Study with [<scp><sup>11</sup>C</scp>]<scp>PBR28</scp> and Machine Learning Analysis
Movement Disorders 2021cited by 39position: middledoi
Patterns of tau pathology identified with <sup>18</sup>F‐MK‐6240 PET imaging
Alzheimer s & Dementia 2021cited by 35position: firstdoi
Neuroinflammation in psychiatric disorders: PET imaging and promising new targets
The Lancet Psychiatry 2020cited by 263position: middledoi
PET imaging of neuroinflammation in neurological disorders
The Lancet Neurology 2020cited by 234position: firstdoi
Antiviral therapy: Valacyclovir Treatment of Alzheimer’s Disease (VALAD) Trial: protocol for a randomised, double-blind,placebo-controlled, treatment trial
BMJ Open 2020cited by 77position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yaakov Stern · Columbia University Irving Medical Center4 papers (2020–2024)Aubrey S. Johnson · Columbia University3 papers (2021–2024)Adam M. Brickman · Columbia University3 papers (2021–2024)Julia Klein · University of Cologne3 papers (2021–2024)Zeljko Tomljanovic · Columbia University3 papers (2021–2024)Davangere P. Devanand · Columbia University3 papers (2020–2021)Seonjoo Lee · New York University3 papers (2021–2024)Akiva Mintz · Columbia University Irving Medical Center3 papers (2020–2025)Qolamreza Razlighi · Cornell University3 papers (2020–2025)Edward P. Acosta · University of Alabama at Birmingham Hospital2 papers (2020–2025) · 2 papers (2021–2021)Lawrence S. Honig · Columbia University Irving Medical Center2 papers (2021–2021)Karen L. Bell · Johns Hopkins University2 papers (2020–2025)Deborah A. Deliyannides · Columbia University2 papers (2020–2025)Anne A. Gershon · Columbia University Irving Medical Center2 papers (2020–2025)Gregory H. Pelton · Columbia University2 papers (2020–2025) · 2 papers (2020–2020)Patrick J. Lao · Columbia University2 papers (2021–2024) · 2 papers (2020–2020)Thomas Wısnıewskı · New York University2 papers (2020–2025)